COMMUNIQUÉS West-GlobeNewswire

Hapbee Announces Launch of Hapbee Experience At Irish Pub in Partnership with BodyTonic

28/06/2024 - 16:40

Shareholders Elect Two New Directors Following Recent Annual General Meeting VANCOUVER, British Columbia, June 28, 2024 (GLOBE NEWSWIRE) -- Hapbee Technologies , Inc. (TSXV: HAPB ) (OTCQB: HAPBF) (FSE: HA1) (“Hapbee” or [...]

Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa

28/06/2024 - 16:27

Bavarian Nordic is committed to support global efforts to address the mpox situation in Africa through a donation of 15,000 doses of mpox vaccine Emergency Use Authorization for the MVA-BN vaccine has been issued in the [...]

YorkTest Announces Limited–Time Offer to Enhance Accessibility of At-Home Health Testing

28/06/2024 - 16:22

WILMINGTON, Del., June 28, 2024 (GLOBE NEWSWIRE) -- YorkTest has launched a new offer to make at-home food sensitivity and allergy testing more accessible to households across the US. This initiative is part of their [...]

KBio Announces FDA Clearance of IND Application for EV68-228-N for the Treatment of Acute Flaccid Myelitis and the First Patient Dosed in the Phase 1 Study

28/06/2024 - 16:17

• The United States Food and Drug Administration (FDA) has cleared the investigational new drug (IND) application for EV68-228-N, a human monoclonal IgG1 against the capsid of enterovirus D68 (EV-D68) designed as an [...]

Vivos Inc. Submits the Application to the FDA for Authority to Initiate Human Clinical Trials

28/06/2024 - 16:15

Richland WA, June 28, 2024 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCQB: RDGL), Vivos Inc. filed the application for an Investigational Device Exemption (“IDE”). The filing was an amendment, addressing the FDA comments to our [...]

Fortrea lance un studio d’innovation en IA pour galvaniser les solutions technologiques et humaines afin d’améliorer la réalisation des essais cliniques

28/06/2024 - 16:08

DURHAM, État de Caroline du Nord, 28 juin 2024 (GLOBE NEWSWIRE) -- Fortrea (Nasdaq : FTRE), un organisme de recherche sous contrat (« ORC ») de premier plan au niveau mondial, a annoncé aujourd’hui le lancement de son [...]

Le KFSH&RC est à l’avant-garde de la révolution mondiale des soins de santé grâce à l’IA et à la robotique

28/06/2024 - 16:05

RIYAD, Arabie saoudite, 28 juin 2024 (GLOBE NEWSWIRE) -- Le King Faisal Specialist Hospital & Research Centre (KFSH&RC) est à la pointe de la révolution mondiale de l’IA et de la robotique. Ces avancées [...]

RYBREVANT®▼ (amivantamab) in combination with chemotherapy is the first therapy approved by the European Commission for the first-line treatment of patients with advanced non-small cell lung cancer with activating EGFR exon 20 insertion mutations

28/06/2024 - 15:52

Approval is supported by the Phase 3 PAPILLON study, which showed amivantamab plus chemotherapy significantly reduced the risk of disease progression or death by 60 percent compared to chemotherapy alone 1 BEERSE, [...]

ORYZON Announces Voting Results from its 2024 Annual General Meeting of Shareholders

28/06/2024 - 15:28

All resolutions were approved Additional resolution to increase capital for up to 100 million euros approved 42.6867% of the issued shares represented MADRID and CAMBRIDGE, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- [...]

Cingulate Announces Exercise of Warrants for $1.86 Million Gross Proceeds

28/06/2024 - 15:15

KANSAS CITY, Kan., June 28, 2024 (GLOBE NEWSWIRE) -- Cingulate Inc. (the “Company”) (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology [...]

Capricor Therapeutics Announces Long-Term Benefit of Deramiocel (CAP-1002) in Both Skeletal Muscle and Cardiac Function in the HOPE-2 OLE Study in Duchenne Muscular Dystrophy

28/06/2024 - 15:00

-Results in Performance of the Upper Limb (PUL v2.0) Continue to Show Slowing of Disease Progression in Later-Stage DMD Patients- -Improvements Seen in Multiple Cardiac Endpoints Demonstrating Stabilization of Cardiac [...]

Elicio Therapeutics Announces Pricing of $11.5 Million Underwritten Public Offering

28/06/2024 - 15:00

BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Elicio Therapeutics, Inc. (Nasdaq: ELTX, “Elicio Therapeutics” or “Elicio”), a clinical-stage biotechnology company developing a pipeline of novel immunotherapies for the [...]

Dyadic International, Inc. and Proliant Health and Biologicals announce Recombinant Albumin Development and Commercialization Partnership

28/06/2024 - 14:30

JUPITER, Fla., June 28, 2024 (GLOBE NEWSWIRE) -- Dyadic International, Inc. (“Dyadic”) (NASDAQ: DYAI), announced today that they have entered into a development and commercialization partnership with Proliant Health and [...]

Intelligent Bio Solutions Completes In-Clinic Portion of Pharmacokinetic (PK) Study Part of 510(k) Pathway for Approval & Commences Review of Results

28/06/2024 - 14:30

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions, today [...]

Safety Shot President Jordan Schur Invests $1 Million in the Company Through his Family Fund, Core 4 Capital Corp.

28/06/2024 - 14:30

This Private Placement Investment Comes in Addition to a $5 Million Investment from Core 4 Capital Corp Which Closed in April JUPITER, FL, June 28, 2024 (GLOBE NEWSWIRE) -- Safety Shot , Inc. (Nasdaq: SHOT) (the “ [...]

Ardelyx Presents Additional Data Detailing Educational Needs Related to IBS-C Management Across Healthcare Disciplines

28/06/2024 - 14:17

WALTHAM, Mass., June 28, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet [...]

Eyenovia Announces Pricing of $5M Registered Direct Offering

28/06/2024 - 14:00

NEW YORK, June 28, 2024 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (“Eyenovia” or the “Company”) (NASDAQ: EYEN), a commercial-stage ophthalmic company, announced today that it has entered into a securities purchase agreement [...]

Rhythm Pharmaceuticals Receives Positive CHMP Opinion for ▼IMCIVREE® (setmelanotide) for the Treatment of Obesity and Control of Hunger in Patients between 2 and 6 years old with Bardet Biedl Syndrome or POMC, PCSK1, or LEPR Deficiency

28/06/2024 - 14:00

- European Commission decision anticipated in the second half of 2024 - BOSTON, June 28, 2024 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused [...]

Soleno Therapeutics Announces Submission of New Drug Application to the U.S. FDA for DCCR (Diazoxide Choline) Extended-Release Tablets for the Treatment of Prader-Willi Syndrome

28/06/2024 - 14:00

REDWOOD CITY, Calif., June 28, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]